Cargando…
Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers
Castration-resistant prostate cancer (CRPC) consists of multiple phenotypic subtypes including androgen receptor (AR)-active prostate cancer (ARPC) and neuroendocrine prostate cancer (NEPC). Tumor cells with these phenotypes can coexist between metastases within a patient and within an individual tu...
Autores principales: | Zhang, Ailin, Lau, Nathan A., Wong, Alicia, Brown, Lisha G., Coleman, Ilsa M., De Sarkar, Navonil, Li, Dapei, DeLucia, Diana C., Labrecque, Mark P., Nguyen, Holly M., Conner, Jennifer L., Dumpit, Ruth F., True, Lawrence D., Lin, Daniel W., Corey, Eva, Alumkal, Joshi J., Nelson, Peter S., Morrissey, Colm, Lee, John K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658857/ https://www.ncbi.nlm.nih.gov/pubmed/37823778 http://dx.doi.org/10.1158/2767-9764.CRC-23-0250 |
Ejemplares similares
-
Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate Cancer
por: Coleman, Ilsa M., et al.
Publicado: (2022) -
Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculature
por: Labrecque, Mark P., et al.
Publicado: (2021) -
Mismatch repair enzyme expression in primary and castrate resistant prostate cancer
por: Nghiem, Belinda, et al.
Publicado: (2016) -
Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4
por: Coleman, Daniel J., et al.
Publicado: (2020) -
Substantial inter-individual and limited intra-individual genomic diversity among tumors from men with metastatic prostate cancer
por: Kumar, Akash, et al.
Publicado: (2016)